Jefferies Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.02M Hold
25,000
0.02% 610
2022
Q2
$2.24M Buy
+25,000
New +$2.53M 0.02% 585
2021
Q3
Sell
-40,000
Closed -$4.97M 1894
2021
Q2
$4.97M Buy
+40,000
New +$5.02M 0.03% 465
2021
Q1
Sell
-10,000
Closed -$1.17M 1845
2020
Q4
$1.17M Hold
10,000
0.01% 890
2020
Q3
$1.04M Sell
10,000
-36,700
-79% -$3.69M 0.01% 787
2020
Q2
$4.28K Buy
46,700
+15,900
+52% +$1.52M 0.05% 310
2020
Q1
$2.78M Buy
30,800
+9,500
+45% +$1.01M 0.03% 524
2019
Q4
$2.42M Buy
21,300
+1,400
+7% +$154K 0.02% 937
2019
Q3
$2.16M Sell
19,900
-138,900
-87% -$14.5M 0.02% 1036
2019
Q2
$15.5M Buy
158,800
+89,600
+129% +$8.18M 0.11% 134
2019
Q1
$6.3M Buy
69,200
+5,800
+9% +$519K 0.05% 354
2018
Q4
$5.77M Sell
63,400
-16,300
-20% -$1.52M 0.05% 361
2018
Q3
$7.84M Buy
79,700
+9,300
+13% +$860K 0.05% 344
2018
Q2
$6.03M Buy
70,400
+58,800
+507% +$4.91M 0.03% 446
2018
Q1
$931K Sell
11,600
-9,200
-44% -$759K 0.01% 1235
2017
Q4
$1.68M Sell
20,800
-59,900
-74% -$4.8M 0.01% 1082
2017
Q3
$6.28M Sell
80,700
-95,600
-54% -$7.94M 0.04% 436
2017
Q2
$15.6M Sell
176,300
-1,800
-1% -$152K 0.1% 172
2017
Q1
$14.3M Buy
178,100
+31,500
+21% +$2.46M 0.11% 175
2016
Q4
$10.4M Buy
146,600
+116,900
+394% +$9.18M 0.06% 332
2016
Q3
$2.57M Sell
29,700
-125,200
-81% -$10.9M 0.01% 812
2016
Q2
$13.4M Buy
154,900
+148,400
+2,283% +$12M 0.06% 210
2016
Q1
$488K Sell
6,500
-82,500
-93% -$6.21M ﹤0.01% 1473
2015
Q4
$6.85M Sell
89,000
-8,500
-9% -$640K 0.04% 353
2015
Q3
$6.53M Buy
97,500
+72,500
+290% +$5.34M 0.04% 389
2015
Q2
$1.85M Buy
+25,000
New +$1.91M 0.01% 952
2015
Q1
Sell
-518,200
Closed -$37.4M 2271
2014
Q4
$37.4M Buy
518,200
+264,100
+104% +$18.3M 0.22% 87
2014
Q3
$15.7M Buy
+254,100
New +$16.2M 0.11% 166
2014
Q1
Sell
-117,200
Closed -$6.73M 2247
2013
Q4
$6.73M Buy
+117,200
New +$6.65M 0.04% 251

Other funds holding MDT

Jefferies Group's MDT Position: Q3 2022 in Review

Jefferies Group increased its Medtronic (MDT) stake by 2,375% in Q3 2022, buying an estimated $719K and bringing the position to 8,341 shares worth $674K. The position accounts for 0.01% of the portfolio, ranked #933.

Jefferies Group first reported a position in MDT in Q2 2013 and has held it in 35 quarters since. The position peaked at $23.9M in Q4 2016. 1,930 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Jefferies Group held 8,341 shares of Medtronic worth $674K as of Q3 2022.
  • Jefferies Group bought 8,004 Medtronic shares in Q3 2022, an estimated $719K.
  • Medtronic made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #933 holding.
  • Jefferies Group first reported a position in Medtronic in Q2 2013 and has held it in 35 quarters since.
  • Jefferies Group's Medtronic position peaked at $23.9M in Q4 2016.
  • 1,930 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.